177 In this episode of the Global Healthcare Innovation Podcast Steven Haken has an interesting discussion with Alastair Hick, the CEO of Uniseed, an Australian venture fund focused on university research commercialisation. Alastair discussed his background in the field and his current role at Uniseed, which invests in spin-outs from its partner universities and CSIRO. He identified the need for faster decision-making and a mindset shift in university commercialisation to avoid delays. Alastair explained that the main constraint is not a shortage of investable opportunities but rather the challenge of moving quickly and accessing larger capital rounds. He emphasised the importance of engaging with the market early to validate commercial potential. Alastair also highlighted the positive changes in the Australian ecosystem, including more support programs and global interest in Australian technology. He advised that Australian spin-outs, especially in life sciences, should target global markets from the outset. The conversation concluded with a discussion on Uniseed’s membership structure and its role in facilitating global research collaborations.